Načítá se...
A Case of Intolerance to Warfarin Dosing in an Intermediate Metabolizer of CYP2C9
We report a case of intolerance to warfarin dosing due to impaired drug metabolism in a patient heterozygous for the CYP2C9*3 allele. A 30-year-old woman with an artificial cardiac pacemaker was taking warfarin to prevent thromboembolism. This patient had an extremely elevated international normaliz...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Yonsei University College of Medicine
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2810600/ https://ncbi.nlm.nih.gov/pubmed/16385662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2005.46.6.843 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|